moxifloxacina aurobindo 400 mg
apl swift services (malta) limited - malta - moxifloxacinum - compr. film. - 400mg - chinolone antibacteriene fluorochinolone
halopril forte 5 mg comprimate
zdorovie narodu srl, Îf din harkov - aciclovirum - comprimate - 5 mg
rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - agenți antineoplazici - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
sumacta 100 mg
actavis hf - islanda - sumatriptanum - compr. film. - 100mg - antimigrenoase agonisti selectivi ai receptorilor serotoninergici (5ht1)
gavreto
roche registration gmbh - pralsetinib - carcinom, pulmonar non-celulă mică - agenți antineoplazici - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
ciprofloxacin 2 mg/ml soluţie perfuzabilă
sichuan kelun pharmaceutical co., ltd. - ciprofloxacinum - soluţie perfuzabilă - 2 mg/ml
co-prenessa comprimate 2 mg + 0,625 mg
krka d.d., novo mesto - perindoprilum + indapamidum - comprimate - 2 mg + 0,625 mg
co-prenessa comprimate 4 mg + 1,25 mg
krka d.d., novo mesto - perindoprilum + indapamidum - comprimate - 4 mg + 1,25 mg
finalgel gel 5 mg/g
boehringer ingelheim international gmbh - piroxicamum - gel - 5 mg/g
levoxa comprimate filmate 250 mg
actavis group ptc ehf. - levofloxacinum - comprimate filmate - 250 mg